Activation of type I interferon-dependent genes characterizes the "core response" induced by CpG DNA

Journal of Leukocyte Biology

Volumn 92, Issue 4, 2012, Pages 775-785

  Steinhagen, Folkert ^a,b   Meyer, Corinna ^a,b   Tross, Debra ^a   Gursel, Mayda ^a,c   Maeda, Takahiro ^d   Klaschik, Sven ^a,b   Klinman, Dennis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

CAL 1; Gene regulation; Human; Oligonucleotide; pDC; TLR9

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; OLIGONUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STIMULATION; CPG ISLAND; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE I; OLIGODEOXYRIBONUCLEOTIDES; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 9;

EID: 84868137189     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1011522     Document Type: Article

References (49)

1. Hemmi, H., Takeuchi, O., Kawai, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
2. Lund, J., Sato, A., Akira, S., Medzhitov, R., Iwasaki, A. (2003) Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520.
3. Gilliet, M., Cao, W., Liu, Y. J. (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606.
4. Klinman, D. M. (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249-258.
5. Gursel, M., Verthelyi, D., Gursel, I., Ishii, K. J., Klinman, D. M. (2002) Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotides. J. Leukoc. Biol. 71, 813-820.
6. Verthelyi, D., Ishii, K. J., Gursel, M., Takeshita, F., Klinman, D. M. (2001) Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J. Immunol. 166, 2372-2377.
7. Yi, A. K., Yoon, J. G., Yeo, S. J., Hong, S. C., English, B. K., Krieg, A. M. (2002) Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J. Immunol. 168, 4711-4720.
8. Takauji, R., Iho, S., Takatsuka, H., Yamamoto, S., Takahashi, T., Kitagawa, H., Iwasaki, H., Iida, R., Yokochi, T., Matsuki, T. (2002) CpGDNA-induced IFN-γ production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors. J. Leukoc. Biol. 72, 1011-1019.
9. Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., Giese, T., Endres, S., Hartmann, G. (2003) Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 170, 4465-4474.
10. Sasai, M., Linehan, M. M., Iwasaki, A. (2010) Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329, 1530-1534.
11. Guiducci, C., Ott, G., Chan, J. H., Damon, E., Calacsan, C., Matray, T., Lee, K. D., Coffman, R. L., Barrat, F. J. (2006) Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203, 1999-2008.
12. Honda, K., Ohba, Y., Yanai, H., Negishi, H., Mizutani, T., Takaoka, A., Taya, C., Taniguchi, T. (2005) Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434, 1035-1040.
13. Kawai, T., Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384.
14. Klaschik, S., Tross, D., Klinman, D. M. (2009) Inductive and suppressive networks regulate TLR9-dependent gene expression in vivo. J. Leukoc. Biol. 85, 788-795.
15. Tross, D., Petrenko, L., Klaschik, S., Zhu, Q., Klinman, D. M. (2009) Global changes in gene expression and synergistic interactions induced by TLR9 and TLR3. Mol. Immunol. 46, 2557-2564.
16. Kato, A., Homma, T., Batchelor, J., Hashimoto, N., Imai, S., Wakiguchi, H., Saito, H., Matsumoto, K. (2003) Interferon-α/β receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4, 8.
17. Amit, I., Garber, M., Chevrier, N., Leite, A. P., Donner, Y., Eisenhaure, T., Guttman, M., Grenier, J. K., Li, W., Zuk, O., Schubert, L. A., Birditt, B., Shay, T., Goren, A., Zhang, X., Smith, Z., Deering, R., McDonald, R. C., Cabili, M., Bernstein, B. E., Rinn, J. L., Meissner, A., Root, D. E., Hacohen, N., Regev, A. (2009) Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326, 257-263.
18. Klaschik, S., Tross, D., Shirota, H., Klinman, D. M. (2010) Short-and long-term changes in gene expression mediated by the activation of TLR9. Mol. Immunol. 47, 1317-1324.
19. Maeda, T., Murata, K., Fukushima, T., Sugahara, K., Tsuruda, K., Anami, M., Onimaru, Y., Tsukasaki, K., Tomonaga, M., Moriuchi, R., Hasegawa, H., Yamada, Y., Kamihira, S. (2005) A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma. Int. J. Hematol. 81, 148-154.
20. Cisse, B., Caton, M. L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., Zweier, C., den Hollander, N. S., Kant, S. G., Holter, W., Rauch, A., Zhuang, Y., Reizis, B. (2008) Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37-48.
21. Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., Liu, Y. J. (1999) The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837.
22. Gallucci, S., Lolkema, M., Matzinger, P. (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 11, 1249-1255.
23. Leifer, C. A., Verthelyi, D., Klinman, D. M. (Jan. 22-27, 2001) CpG ODN mixtures optimally activate human PBMC: interfaces between innate and adaptive immunity. In Keystone Symposia, Keystone, CO, USA (abs. 22).
24. Klaschik, S., Gursel, I., Klinman, D. M. (2007) CpG-mediated changes in gene expression in murine spleen cells identified by microarray analysis. Mol. Immunol. 44, 1095-1104.
25. Wright, G. W., Simon, R. M. (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19, 2448-2455.
26. Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., Krieg, A. M. (2004) Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34, 251-262.
27. Haas, T., Metzger, J., Schmitz, F., Heit, A., Muller, T., Latz, E., Wagner, H. (2008) The DNA sugar backbone 2' deoxyribose determines Toll-like receptor 9 activation. Immunity 28, 315-323.
28. Cooper, C. L., Ahluwalia, N. K., Efler, S. M., Vollmer, J., Krieg, A. M., Davis, H. L. (2008) Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers. J. Immune Based Ther. Vaccines 6, 3.
29. Gursel, M., Gursel, I., Mostowski, H. S., Klinman, D. M. (2006) CXCL16 influences the nature and specificity of CpG-induced immune activation. J. Immunol. 177, 1575-1580.
30. Colonna, M., Trinchieri, G., Liu, Y. J. (2004) Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226.
31. Reizis, B., Colonna, M., Trinchieri, G., Barrat, F., Gilliet, M. (2011) Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat. Rev. Immunol. 11, 558-565.
32. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., Hartmann, G. (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163.
33. Liu, Y. C., Gray, R. C., Hardy, G. A., Kuchtey, J., Abbott, D. W., Emancipator, S. N., Harding, C. V. (2010) CpG-B oligodeoxynucleotides inhibit TLR-dependent and-independent induction of type I IFN in dendritic cells. J. Immunol. 184, 3367-3376.
34. Sadler, A. J., Williams, B. R. (2008) Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8, 559-568.
35. Schoggins, J. W., Nociari, M., Philpott, N., Falck-Pedersen, E. (2005) Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation. J. Virol. 79, 11627-11637.
36. Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B., Virgin, H. W. (2005) Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79, 13974-13983.
37. Arnheiter, H., Skuntz, S., Noteborn, M., Chang, S., Meier, E. (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62, 51-61.
38. Zhou, A., Paranjape, J., Brown, T. L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, B., Fairchild, R., Colmenares, C., Silverman, R. H. (1997) Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
39. Yakub, I., Lillibridge, K. M., Moran, A., Gonzalez, O. Y., Belmont, J., Gibbs, R. A., Tweardy, D. J. (2005) Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection. J. Infect. Dis. 192, 1741-1748.
40. Knapp, S., Yee, L. J., Frodsham, A. J., Hennig, B. J., Hellier, S., Zhang, L., Wright, M., Chiaramonte, M., Graves, M., Thomas, H. C., Hill, A. V., Thursz, M. R. (2003) Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun. 4, 411-419.
41. Hijikata, M., Ohta, Y., Mishiro, S. (2000) Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt-88) correlated with the response of hepatitis C patients to interferon. Intervirology 43, 124-127.
42. Ashkar, A. A., Bauer, S., Mitchell, W. J., Vieira, J., Rosenthal, K. L. (2003) Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2. J. Virol. 77, 8948-8956.
43. Svensson, A., Bellner, L., Magnusson, M., Eriksson, K. (2007) Role of IFN-α/β signaling in the prevention of genital herpes virus type 2 infection. J. Reprod. Immunol. 74, 114-123.
44. Shen, H., Iwasaki, A. (2006) A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J. Clin. Invest. 116, 2237-2243.
45. Rees, D. G., Gates, A. J., Green, M., Eastaugh, L., Lukaszewski, R. A., Griffin, K. F., Krieg, A. M., Titball, R. W. (2005) CpG-DNA protects against a lethal orthopoxvirus infection in a murine model. Antiviral Res. 65, 87-95.
46. Krieg, A. M., Efler, S. M., Wittpoth, M., Al Adhami, M. J., Davis, H. L. (2004) Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist. J Immunother. 27, 460-471.
47. Krieg, A. M., Homan, L. L., Yi, A. K., Harty, J. T. (1998) CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161, 2428-2434.
48. Elkins, K. L., Rhinehart-Jones, T. R., Stibitz, S., Conover, J. S., Klinman, D. M. (1999) Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162, 2291-2298.
49. Weighardt, H., Feterowski, C., Veit, M., Rump, M., Wagner, H., Holzmann, B. (2000) Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J. Immunol. 165, 4537-4543.